M Rosenzwajg, A Gherasim, F Dietsch, M. Beck, N Domis, R Lorenzon, Yannick Chantran, B Bellier, E Vicaut, A Soria, F De Blay, D Klatzmann
{"title":"Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial","authors":"M Rosenzwajg, A Gherasim, F Dietsch, M. Beck, N Domis, R Lorenzon, Yannick Chantran, B Bellier, E Vicaut, A Soria, F De Blay, D Klatzmann","doi":"10.1101/2024.09.04.24312986","DOIUrl":null,"url":null,"abstract":"<strong>Background</strong> Regulatory T cells (Tregs) are pivotal in immune tolerance to allergens. Low-dose IL-2 (IL-2<sub>LD</sub>) expands and activates Tregs. We assessed IL-2<sub>LD</sub> efficacy for controlling clinical responses to allergen exposures.","PeriodicalId":501527,"journal":{"name":"medRxiv - Allergy and Immunology","volume":"264 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Allergy and Immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.09.04.24312986","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background Regulatory T cells (Tregs) are pivotal in immune tolerance to allergens. Low-dose IL-2 (IL-2LD) expands and activates Tregs. We assessed IL-2LD efficacy for controlling clinical responses to allergen exposures.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
